| |
| Issue |
Title |
| |
| Vol 25, No 4 (2025) |
Reference standards for evaluating the potency of human immunoglobulin preparations: Literature review |
Abstract
PDF (Rus)
|
|
E. S. Kormshchikova, E. N. Kalinina, E. A. Konovalova, E. V. Rosina, N. S. Vildanova, S. E. Ziganshina, K. A. Vorobiev, I. V. Paramonov |
| |
| Vol 25, No 4 (2025) |
Pharmacokinetic assessment of two IgG1 kappa monoclonal antibodies neutralising the SARS-CoV-2: A study in Syrian hamsters and ICR CD1 outbred mice |
Abstract
PDF (Rus)
|
|
T. N. Barybina, N. M. Faustova, M. V. Karlina, V. M. Kosman, P. P. Solodkov, S. V. Kulemzin, M. N. Makarova, V. G. Makarov |
| |
| Vol 25, No 4 (2025) |
Protective efficacy of combined monoclonal antibody docaravimab and miromavimab preparation against classical rabies virus: A preclinical study in BALB/c mice |
Abstract
PDF (Rus)
|
|
S. V. Borisevich, V. V. Rubtsov, M. N. Pistsov, S. Ya. Loginova, V. T. Krotkov, R. V. Sakharov, D. A. Kuznetsov, T. E. Sizikova, S. V. Savenko, K. I. Yanovskaya, A. V. Ovchinnikov, A. N. Mironov |
| |
| Vol 25, No 4 (2025) |
Human hepatitis B immunoglobulin for intravenous administration: Development, quality control, viral safety, and pharmacokinetics research |
Abstract
PDF (Rus)
|
|
A. V. Ivanov, O. V. Beliakova, A. I. Semicheva, T. V. Vyaznikova, E. I. Sakanjan, T. I. Smolyanova, А. R. Sokolova, D. M. Trofimov, A. M. Nikolaeva |
| |
| Vol 25, No 4 (2025) |
Clinical trials and post-marketing studies of anti-rabies monoclonal antibodies for post-exposure prevention: A review |
Abstract
PDF (Rus)
|
|
A. Yu. Butirskiy, A. S. Korovkin, A. A. Movsesyants, V. A. Merkulov |
| |
| 1 - 5 of 5 Items |
|
